SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biochem Pharma (BCHE)
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
783 13 0 BCHE
Emcee:  Constant Reader Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
258 so we had the news release,....what do you guys think will happen to the share rodin999-3/18/1998
257 Bche had a diagnostic arm that was supposed to split as you said . It will sepaWilfredo Pagani-3/18/1998
256 Patient...I have but time I don't ....pretty ironic but it's the truth.Patounet-3/18/1998
255 Biochem Pharma Inc. - Combivir, First Tablet To Combine Two Anti-Hiv Drugs, AppRichard Haugland-3/18/1998
254 looks like your claim has not been annouced as yet.....where are you ........tarodin999-3/17/1998
253 Must be another news then the FDA approval cause I heard that this will only taPatounet-3/17/1998
252 Lamouduline or 3tc which is the other retroviral agent of Glaxo combivir is theWilfredo Pagani-3/17/1998
251 Patounet, I hear you!!! Go BCHE!!!!Steve Goldstein-3/16/1998
250 Thanks, Patounet. Are you sure this is something new and not a rehash of LamivJohn Metcalf-3/15/1998
249 Steve, My info is hard like rock. If you have some be happy and look at your Patounet-3/15/1998
248 Patounet, Your message certainly caught my attention. I have been waiting for GSteve Goldstein-3/15/1998
247 HI all... I heard an inside tonight about BCH. Early this week (Monday or TuesPatounet-3/14/1998
246 Biochem Pharma Appoints Jacques Lapointe President And Chief Operating Officer Richard Haugland-3/12/1998
245 Check out this company DynaGen Receives Notice of Allowance for U.S. Patent emichael-3/4/1998
244 Steve- This are purely technical movements, related to the resistance area I mTodd D. Wiener-2/20/1998
243 Todd, What happened today? Some profit taking or bad news? BCHE was down some tSteve Goldstein-2/19/1998
242 Actually, BCHE is entering a stiff resistance area, defined by its recent downtTodd D. Wiener-2/11/1998
241 Anyone care to look at BCHE from a technical standpoint,This chart says BUY ME!thebeach-2/9/1998
240 Biochem Pharma Inc. Forms New R&D Corporation - Plans To Issue Dividend-In-Todd D. Wiener-2/9/1998
239 Thanks for the post,sure sets the stage for a little tug of war for Biochem,doethebeach-2/9/1998
238 BioChem Pharma Eyes SmithKline Tie-Up For Influenza Vaccine By BEN DUMMETT DTodd D. Wiener-2/9/1998
237 johne, Patience & "Patients." I like that. Thanks.Steve Goldstein-2/8/1998
236 Steve; I don't know why the bombings took place.It shouldn't have any johne-2/7/1998
235 johne, Thanks for your comments. Do you feel the recent bombing incident hurt tSteve Goldstein-2/7/1998
234 Wednesday February 4, 5:00 pm Eastern Time Glaxo /SmithKline merger to spark R&richard-2/6/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News